Michael P. Zawistoski

Person

West Warwick, RI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds and methods for the treatment of cystic fibrosis
- Patent number 10,072,017
- Issue date Sep 11, 2018
- Flatley Discovery Lab, LLC
- Michael P. Zawistoski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for the treatment of cystic fibrosis
- Patent number 9,944,603
- Issue date Apr 17, 2018
- Flatley Discovery Lab, LLC
- Michael P. Zawistoski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for the treatment of cystic fibrosis
- Patent number 9,771,327
- Issue date Sep 26, 2017
- Flatley Discovery Lab, LLC
- Michael P. Zawistoski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of insulin resistance
- Patent number 6,867,202
- Issue date Mar 15, 2005
- Pfizer Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of insulin resistance with growth hormone secretagogues
- Patent number 6,630,487
- Issue date Oct 7, 2003
- Pfizer Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
- Patent number 6,608,203
- Issue date Aug 19, 2003
- Pfizer Inc.
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of insulin resistance with growth hormone secretagogues
- Patent number 6,448,263
- Issue date Sep 10, 2002
- Pfizer Inc.
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
- Publication number 20170313659
- Publication date Nov 2, 2017
- Flatley Discovery Lab, LLC
- Michael P. Zawistoski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
- Publication number 20170204110
- Publication date Jul 20, 2017
- Flatley Discovery Lab, LLC
- Michael P. Zawistoski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
- Publication number 20140371263
- Publication date Dec 18, 2014
- FLATLEY DISCOVERY LAB
- Michael P. Zawistoski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
- Publication number 20140371238
- Publication date Dec 18, 2014
- FLATLEY DISCOVERY LAB
- Michael P. Zawistoski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
- Publication number 20040192685
- Publication date Sep 30, 2004
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
- Publication number 20030220494
- Publication date Nov 27, 2003
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of insulin resistance with growth hormone secretagogues
- Publication number 20030100561
- Publication date May 29, 2003
- Philip Albert Carpino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
- Publication number 20010039285
- Publication date Nov 8, 2001
- Kimberly O. Cameron
- C07 - ORGANIC CHEMISTRY

Michael P. Zawistoski

Person

Patents Grantslast 30 patents

Compounds and methods for the treatment of cystic fibrosis

Compounds and methods for the treatment of cystic fibrosis

Compounds and methods for the treatment of cystic fibrosis

Treatment of insulin resistance

Treatment of insulin resistance with growth hormone secretagogues

Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

Treatment of insulin resistance with growth hormone secretagogues

Patents Applicationslast 30 patents

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

Treatment of insulin resistance with growth hormone secretagogues

Tetrahydroisoquinoline compounds as estrogen agonists/antagonists